Company Overview: Surmodics, Inc. (NASDAQ: SRDX) specializes in medical device coating technologies and in vitro diagnostic components. The company focuses on vascular intervention products and has recently been involved in a merger agreement potentially worth $43.00 per share with BCE Parent LLC...